Strength
300 mg/1
Manufacturer
AvPAKNDC
50268018515
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207402On Market Since
10/27/2020
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has been published 281 times since Feb 10, 2021, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1724 per EA |
|---|---|
| All-time high | $0.2913 (Jun 16, 2021) |
| All-time low | $0.1674 (Nov 20, 2024) |
| 52-week high | $0.1947 |
| 52-week low | $0.1724 |
| Median price | $0.2339 |
| Average price | $0.2273 |
| Largest weekly change | +33.6% (Aug 21, 2024) |
| Weeks tracked | 281 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 300 MG CAPSULE, manufactured by AvPAK, is $0.1724 per EA (NDC 50268018515), effective Jun 24, 2026.
How has the price of CLINDAMYCIN HCL 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has declined 34.6%. It has been tracked across 281 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 300 MG CAPSULE?
Since Feb 10, 2021, the NADAC for CLINDAMYCIN HCL 300 MG CAPSULE has ranged from a low of $0.1674 (Nov 20, 2024) to a high of $0.2913 (Jun 16, 2021), with a median of $0.2339 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 300 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CLINDAMYCIN HCL 300 MG CAPSULE, but none are currently priced below it.
Who manufactures CLINDAMYCIN HCL 300 MG CAPSULE?
CLINDAMYCIN HCL 300 MG CAPSULE (NDC 50268018515) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification